GeneDx Holdings Corp. (WGS)
68.53
-2.99
(-4.18%)
USD |
NASDAQ |
Oct 07, 16:00
67.00
-1.53
(-2.23%)
After-Hours: 07:24
GeneDx Holdings Total Liabilities (Quarterly) : 237.26M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 237.26M |
| March 31, 2026 | 252.18M |
| December 31, 2025 | 262.01M |
| September 30, 2025 | 201.64M |
| June 30, 2025 | 186.73M |
| March 31, 2025 | 189.02M |
| December 31, 2024 | 219.46M |
| September 30, 2024 | 204.34M |
| June 30, 2024 | 195.06M |
| March 31, 2024 | 187.31M |
| December 31, 2023 | 245.66M |
| September 30, 2023 | 163.03M |
| Date | Value |
|---|---|
| June 30, 2023 | 180.28M |
| March 31, 2023 | 216.83M |
| December 31, 2022 | 291.56M |
| September 30, 2022 | 267.68M |
| June 30, 2022 | 296.01M |
| March 31, 2022 | 188.23M |
| December 31, 2021 | 165.99M |
| September 30, 2021 | 212.09M |
| June 30, 2021 | 130.42M |
| March 31, 2021 | 143.95M |
| December 31, 2020 | 247.25M |
| September 30, 2020 | 15.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Twist Bioscience Corp. | 226.70M |
| CS Diagnostics Corp. | 0.0153M |
| Aibotics, Inc. | 5.152M |
| Intellia Therapeutics, Inc. | 129.46M |
| 10X Genomics, Inc. | 204.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 481.49M |
| Shareholders Equity (Quarterly) | 244.22M |
| Debt to Equity Ratio | 0.6855 |
| Current Ratio | 3.301 |
| Net Debt Paydown Yield | -0.50% |